tiprankstipranks
Trending News
More News >
Balaxi Pharmaceuticals Limited (IN:BALAXI)
:BALAXI
India Market

Balaxi Pharmaceuticals Limited (BALAXI) Financial Statements

Compare
0 Followers

Balaxi Pharmaceuticals Limited Financial Overview

Balaxi Pharmaceuticals Limited's market cap is currently ₹280.90M. The company's EPS TTM is ₹; its P/E ratio is 7.01; Balaxi Pharmaceuticals Limited is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 2.89B₹ 2.41B₹ 3.36B₹ 2.79B₹ 2.31B
Gross Profit₹ 1.27B₹ 1.13B₹ 1.34B₹ 837.91M₹ 591.85M
Operating Income₹ 363.99M₹ 467.31M₹ 586.30M₹ 503.11M₹ 424.17M
EBITDA₹ 305.64M₹ 456.59M₹ 603.82M₹ 560.20M₹ 449.86M
Net Income₹ 250.70M₹ -23.87M₹ 459.63M₹ 476.58M₹ 381.37M
Balance Sheet
Cash & Short-Term Investments₹ 394.00M₹ 622.91M₹ 282.17M₹ 71.93M₹ 16.69M
Total Assets₹ 3.10B₹ 2.58B₹ 2.40B₹ 1.76B₹ 996.80M
Total Debt₹ 534.25M₹ 194.04M₹ 133.06M₹ 36.38M₹ 36.59M
Net Debt₹ 140.26M₹ -428.87M₹ -149.10M₹ -35.55M₹ 19.90M
Total Liabilities₹ 786.06M₹ 569.79M₹ 567.89M₹ 633.07M₹ 347.00M
Stockholders' Equity₹ 2.32B₹ 2.01B₹ 1.83B₹ 1.13B₹ 649.80M
Cash Flow
Free Cash Flow₹ -589.01M₹ 32.97M₹ -89.05M₹ 68.00M₹ -25.53M
Operating Cash Flow₹ -377.82M₹ 48.66M₹ 60.75M₹ 341.44M₹ 32.00K
Investing Cash Flow₹ -217.64M₹ -10.46M₹ -105.65M₹ -284.48M₹ -59.73M
Financing Cash Flow₹ 366.55M₹ 302.54M₹ 255.13M₹ -1.63M₹ 36.46M
Currency in INR

Balaxi Pharmaceuticals Limited Earnings and Revenue History

Balaxi Pharmaceuticals Limited Debt to Assets

Balaxi Pharmaceuticals Limited Cash Flow

Balaxi Pharmaceuticals Limited Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.